Item NHL Patient (number-%)
Sex (Male/Female) 60/40 3:2
B-symptoms: Fever, night sweats, weight loss 30/100 30%
Lymphadenopathy 74/100 74%
Groups of lymphnodes involved - Cervical 46/100 46%
- Axillary 32/100 32%
- Inguinal 27/100 27%
- Abdominal 17/100 17%
- Submandibular 15/100 15%
- Para-aortic 13/100 13%
- Mesenteric 3/100 3%
Extranodal involvement (GIT, bone, kidney, skinorliver) 51/100 51%
Splenomegaly 36/100 36%
Hepatomegaly 23/100 23%
Clinical Stage:
IA
IB
IIA
IIB
IIIA
IIIB
IVA
IVB
15/100
1/100
12/100
4/100
20/100
10/100
22/100
16/100
15%
1%
12%
4%
20%
10%
22%
16%
Performance status:
Score0
ScoreI
ScoreII
ScoreIII
ScoreIV
2/100
70/100
16/100
9/100
3/100
2%
70%
16%
9%
3%
Pathological subtypes:
Diffuse large B-cell lymphoma (DLBCL)
Follicular lymphoma (FL)
Small lymphocytic lymphoma (SLL)
T-cellrich B-cell lymphoma
Mantle Zone Lymphoma (MZL)
78/100
7/100
7/100
4/100
4/100
78%
7%
7%
4%
4%
IPI
0
1
2
3
4
13/100
29/100
35/100
18/100
5/100
13%
29%
35%
18%
5%
Response to treatment:
Complete remission(CR)
Partial remission(PR)
Partial disease(PD)
Relapse
Died
Stopped treatment upon request
Unavailable
12/100
14/100
6/100
33/100
5/100
9/100
21/100
12%
14%
6%
33%
5%
9%
21%
IPI: International prognostic index
Table 1: The demographic characteristics of NHL patients at presentation.